Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The value of immunotherapy in head and neck cancer.
Manca P, Raez LE, Salzberg M, Sanchez J, Hunis B, Rolfo C. Manca P, et al. Expert Opin Biol Ther. 2019 Jan;19(1):35-43. doi: 10.1080/14712598.2019.1556637. Epub 2018 Dec 20. Expert Opin Biol Ther. 2019. PMID: 30537444 Review.
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases.
Marmorino F, Prisciandaro M, Giordano M, Ortolan E, Crucitta S, Manca P, Antoniotti C, Valenti MM, Danesi R, Conca V, Mazzoli G, Boccaccino A, Carullo M, Martinetti A, Sottotetti E, Masi G, Sposito C, Zaffaroni N, Milione M, Fontanini G, Del Re M, Pietrantonio F, Cremolini C. Marmorino F, et al. Among authors: manca p. JCO Precis Oncol. 2022 Nov;6:e2200244. doi: 10.1200/PO.22.00244. JCO Precis Oncol. 2022. PMID: 36356286
ROS-1 Rearrangements in Circulating Tumor Cells.
Raez LE, Manca P, Rolfo C, Singh V. Raez LE, et al. Among authors: manca p. J Thorac Oncol. 2018 May;13(5):e71-e72. doi: 10.1016/j.jtho.2017.11.127. J Thorac Oncol. 2018. PMID: 29703538 Free article. No abstract available.
Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer.
Rolfo C, Manca P, Salgado R, Van Dam P, Dendooven A, Ferri Gandia J, Rutten A, Lybaert W, Vermeij J, Gevaert T, Weyn C, Lefebure A, Metsu S, Van Laere S, Peeters M, Pauwels P, Machado Coelho A. Rolfo C, et al. Among authors: manca p. ESMO Open. 2018 Jul 23;3(5):e000398. doi: 10.1136/esmoopen-2018-000398. eCollection 2018. ESMO Open. 2018. PMID: 30094075 Free PMC article.
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer.
de Miguel-Perez D, Russo A, Arrieta O, Ak M, Barron F, Gunasekaran M, Mamindla P, Lara-Mejia L, Peterson CB, Er ME, Peddagangireddy V, Buemi F, Cooper B, Manca P, Lapidus RG, Hsia RC, Cardona AF, Naing A, Kaushal S, Hirsch FR, Mack PC, Serrano MJ, Adamo V, Colen RR, Rolfo C. de Miguel-Perez D, et al. Among authors: manca p. J Exp Clin Cancer Res. 2022 Jun 2;41(1):186. doi: 10.1186/s13046-022-02379-1. J Exp Clin Cancer Res. 2022. PMID: 35650597 Free PMC article.
Exosomes as diagnostic and predictive biomarkers in lung cancer.
Reclusa P, Taverna S, Pucci M, Durendez E, Calabuig S, Manca P, Serrano MJ, Sober L, Pauwels P, Russo A, Rolfo C. Reclusa P, et al. Among authors: manca p. J Thorac Dis. 2017 Oct;9(Suppl 13):S1373-S1382. doi: 10.21037/jtd.2017.10.67. J Thorac Dis. 2017. PMID: 29184676 Free PMC article. Review.
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients.
Pantano F, Zalfa F, Iuliani M, Simonetti S, Manca P, Napolitano A, Tiberi S, Russano M, Citarella F, Foderaro S, Vulpis E, Zingoni A, Masuelli L, Bei R, Ribelli G, Del Re M, Danesi R, Vincenzi B, Perrone G, Tonini G, Santini D. Pantano F, et al. Among authors: manca p. Cancers (Basel). 2022 May 14;14(10):2435. doi: 10.3390/cancers14102435. Cancers (Basel). 2022. PMID: 35626040 Free PMC article.
136 results